These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 33655513)

  • 21. Mild recessive dystrophic epidermolysis bullosa associated with two compound heterozygous COL7A1 mutations.
    von Bartenwerffer W; Has C; Arin MJ; Tantcheva-Poór I; Kreuter A; Kremer K; Arshah T; Hoffmann M; Eming SA; Kohlhase J; Krieg T; Bruckner-Tuderman L; Hartmann K
    Eur J Dermatol; 2011; 21(2):170-2. PubMed ID: 21382783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Wound closure by secondary intention is successful in the treatment of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
    Rodríguez-Lojo R; Fernández-Jorge B; DE Andrés A; Peña C; García-Silva J
    Eur J Dermatol; 2011; 21(2):302-3. PubMed ID: 21540143
    [No Abstract]   [Full Text] [Related]  

  • 23. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP; O'Toole EA
    Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of recessive dystrophic epidermolysis bullosa treated with a cultured epidermal autograft.
    Mochizuki R; Oka Y; Hashimoto S; Shiraki E; Ogo M; Jimbo H; Nakano E; Fujiwara S; Nagano T; Nishigori C
    J Dermatol; 2021 Apr; 48(4):e165-e166. PubMed ID: 33523491
    [No Abstract]   [Full Text] [Related]  

  • 25. Recessive dystrophic epidermolysis bullosa complicated with nephrotic syndrome due to secondary amyloidosis.
    Gündüz K; Vatansever S; Türel A; Sen S
    Int J Dermatol; 2000 Feb; 39(2):151-3. PubMed ID: 10692067
    [No Abstract]   [Full Text] [Related]  

  • 26. Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation.
    Bodemer C; Tchen SI; Ghomrasseni S; Séguier S; Gaultier F; Fraitag S; de Prost Y; Godeau G
    J Invest Dermatol; 2003 Aug; 121(2):273-9. PubMed ID: 12880418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case Report: Recessive Dystrophic Epidermolysis Bullosa With Severe Esophageal Stenosis: A Case Report and Literature Review.
    Xu Z; Huang T; Pan M; Huang Y; Jiang Y
    Br J Biomed Sci; 2022; 79():10200. PubMed ID: 35996499
    [No Abstract]   [Full Text] [Related]  

  • 28. Darbepoetin alfa and ferric gluconate ameliorate the anemia associated with recessive dystrophic epidermolysis bullosa.
    Kuo DJ; Bruckner AL; Jeng MR
    Pediatr Dermatol; 2006; 23(6):580-5. PubMed ID: 17156003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complex genetic models in dystrophic epidermolysis bullosa families with marked intra-familial phenotypic heterogeneity.
    Chen F; Wang Y; Wang X; Yao Z; Li M
    J Eur Acad Dermatol Venereol; 2022 Jul; 36(7):e550-e553. PubMed ID: 35181940
    [No Abstract]   [Full Text] [Related]  

  • 30. Electrochemotherapy, a local treatment for squamous cell carcinoma in patients with recessive dystrophic epidermolysis bullosa.
    Bartolo J; Farricha V; Carvalhal S; Moura C; Abecasis N
    Dermatol Ther; 2020 Nov; 33(6):e14093. PubMed ID: 32720460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral manifestations as the main feature of late-onset recessive dystrophic epidermolysis bullosa.
    Schauer F; Hoffmann J; Fischer J; Has C
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):e161-e163. PubMed ID: 29080321
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical algorithm to manage anemia in epidermolysis bullosa.
    Simpson B; Tarango C; Lucky AW
    Pediatr Dermatol; 2018 Sep; 35(5):e319-e320. PubMed ID: 29974505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression.
    McGrath JA; Ishida-Yamamoto A; O'Grady A; Leigh IM; Eady RA
    J Invest Dermatol; 1993 Apr; 100(4):366-72. PubMed ID: 8454899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Sporadic" dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?
    Vaccaro M; Moretti G; Guarneri F; Cannavò S; Magaudda L
    Eur J Dermatol; 2000 Aug; 10(6):436-8. PubMed ID: 10980463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purified oral cannabidiol for pain management in severe recessive dystrophic epidermolysis bullosa.
    Welponer T; Diem A; Nahler G; Laimer M
    Indian J Dermatol Venereol Leprol; 2022; 88(4):551-552. PubMed ID: 35593277
    [No Abstract]   [Full Text] [Related]  

  • 37. Ophthalmologic Approach in Epidermolysis Bullosa: A Cross-Sectional Study With Phenotype-Genotype Correlations.
    Mellado F; Fuentes I; Palisson F; I Vergara J; Kantor A
    Cornea; 2018 Apr; 37(4):442-447. PubMed ID: 29384803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The eye in epidermolysis bullosa.
    Tong L; Hodgkins PR; Denyer J; Brosnahan D; Harper J; Russell-Eggitt I; Taylor DS; Atherton D
    Br J Ophthalmol; 1999 Mar; 83(3):323-6. PubMed ID: 10365041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Periungual eccrine poroma.
    Fierro-Arias L; Calderón L; Peniche-Castellanos A; Mercadillo-Pérez P
    J Cutan Med Surg; 2015; 19(1):84-6. PubMed ID: 25775671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The novel application of syringe needle in recessive dystrophic epidermolysis bullosa syndactyly release surgery.
    Wu C; Zhang W; Zhou K; Zhang X; Deng D
    J Am Acad Dermatol; 2024 May; 90(5):e165-e166. PubMed ID: 37977295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.